Analysis Metabolite Name Measured Value Units Exercise Group Sex Type
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-2084Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-2127Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-2442Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-2560Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-2980Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-3065Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-3124Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-3619Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4075Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4235Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4371Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4413Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4475Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4611Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4640Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4657Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-4788Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5297Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5329Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5378Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5484Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5646Peak area normalizedYes PAH Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5675Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5780Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5898Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-5991Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6008Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6051Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6055Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6347Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6620Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6703Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6820Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-6971Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7020Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7031Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7152Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7482Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7548Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7552Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7569Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7637Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7685Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7697Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-7748Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8035Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8108Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8125Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8162Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8408Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8472Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8688Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8698Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-8882Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9077Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9292Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9483Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9706Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9830Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9904Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9917Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9921Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9922Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-9966Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10023Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10051Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10238Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10327Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10356Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10413Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10444Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10654Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10691Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10824Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-10838Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11131Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11158Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11168Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11379Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11398Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11440Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11544Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11685Peak area normalizedYes PAH Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11726Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11854Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11895Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-11999Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-12069Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-12646Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-12667Peak area normalizedYes PAH Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-12723Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-12737Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-12981Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13007Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13151Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13320Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13583Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13638Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13707Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13863Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13967Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13984Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-13995Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14056Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14182Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14274Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14380Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14407Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14627Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14668Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-14912Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-15300Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-15469Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-15712Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-15843Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-15904Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-16477Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-16546Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-16571Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-16617Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-16676Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-16733Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-16986Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-17255Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-17268Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-17465Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-17764Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-18513Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-18743Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-18934Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-19375Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-19521Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-20461Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-20471Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-20509Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-20535Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-22050Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-22478Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-22795Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-23424Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-23596Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-24001Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-24958Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-27303Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-27698Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-28107Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-28266Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-28898Peak area normalizedYes PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-29212Peak area normalizedYes Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-30623Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-36456Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo Healthy Male Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo Normal Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo PAH Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedNo PAH Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedYes Healthy Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedYes Normal Pressures Female Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedYes Normal Pressures Male Cath
Reversed phase NEGATIVE ION MODETHYMIDINE (M+CL)-Peak area normalizedYes PAH Female Cath

Return to search page
  logo